CDD-1845 structure
|
Common Name | CDD-1845 | ||
|---|---|---|---|---|
| CAS Number | 2894104-50-6 | Molecular Weight | 541.64 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C34H31N5O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of CDD-1845CDD-1845 is a non-covalent and non-peptide potent SARS-CoV-2 Mpro inhibitor with a Ki of 3 nM. CDD-1845 also inhibits ΔP168, A173V, and ΔP168/A173V Mpro variants[1]. |
| Name | CDD-1845 |
|---|
| Description | CDD-1845 is a non-covalent and non-peptide potent SARS-CoV-2 Mpro inhibitor with a Ki of 3 nM. CDD-1845 also inhibits ΔP168, A173V, and ΔP168/A173V Mpro variants[1]. |
|---|---|
| Related Catalog | |
| Target |
Ki: 3 nM (SARS-CoV-2 Mpro)[1] |
| References |
| Molecular Formula | C34H31N5O2 |
|---|---|
| Molecular Weight | 541.64 |